Recent Updates
Recently added Catalysts

DCE-MRI scans, Gadobutrol

Phase 1

Heart Failure, Congestive | Unknown | Cardiovascular |GSK plc|Last Updated: Feb 27, 2019

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedCONTROLLEDBiomarker
Total Trials1
Total Enrollment41
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02135861A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac FailurePHASE1 COMPLETED 41Jul 30, 2014Feb 22, 2017Feb 27, 20191 United Kingdom
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Interstitial Volume (ve) in Heart Failure Participants and Healthy Volunteers at Baseline
Day 1

Interstitial volume (ve) was measured by DCE-MRI. ve for total lung, left lung, right lung, left lung apical, left lung basal, right lung apical, right lung basal has been presented. Session 1 values were considered as Baseline values.

Exchange Rate (Ktrans) in Heart Failure Participants and Healthy Volunteers at Baseline
Day 1

Exchange rate (Ktrans) was measured by DCE-MRI. Ktrans for total lung, left lung, right lung, left lung apical, left lung basal, right lung apical, right lung basal has been presented. Session 1 values were considered as Baseline values.

Interstitial Volume (ve) in Heart Failure Participants and Healthy Volunteers Before and Following Exercise
Day 11

Interstitial volume (ve) was measured by DCE-MRI. ve for total lung, left lung, right lung, left lung apical, left lung basal, right lung apical, right lung basal before and following exercise has been presented.

Exchange Rate (Ktrans) in Heart Failure Participants and Healthy Volunteers Before and Following Exercise
Day 11

Exchange rate (Ktrans) was measured by DCE-MRI. Ktrans for total lung, left lung, right lung, left lung apical, left lung basal, right lung apical, right lung basal before and following exercise has been presented.

Change in Interstitial Volume (ve) in ADHF Participants
Up to Week 8

Interstitial volume (ve) was measured by DCE-MRI. Three participants underwent 3 DCE-MRI scans. The data has been presented for individual participant in each session. The data presented below is only for total lung.

Change in Exchange Rate (Ktrans) in ADHF Participants
Up to Week 8

Exchange rate (Ktrans) was measured by DCE-MRI. Three participants underwent 3 DCE-MRI scans. The data has been presented for individual participant in each session. The data presented below is only for total lung.

Secondary Endpoints
Assessment of Intra-subject Variability in Ve Between Session 1 and Session 2 of DCE-MRI
Day 1 (Session 1) and Day 9 (Session 2)
Assessment of Intra-subject Variability in Ktrans Between Session 1 and Session 2 of DCE-MRI
Day 1 (Session 1) and Day 9 (Session 2)
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelSINGLE_GROUP
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
Healthy volunteersEXPERIMENTALAll subjects will undergo MRI scanning conducted by experienced radiographers and radiologists in the nominated scanning sites, using a 1.5 Tesla (T) system.
Heart failure patientsEXPERIMENTALAll subjects will undergo DCE-MRI scanning conducted by experienced radiographers and radiologists in the nominated scanning sites, using a 1.5 T system.
Acute decompensated heart failureEXPERIMENTALAll subjects will undergo DCE-MRI scanning conducted by experienced radiographers and radiologists in the nominated scanning sites, using a 1.5 T system
Interventions
NameTypeDescription
DCE-MRI scansPROCEDURESubjects will be placed supine in the scanner and will be prepared for intravenous contrast agent administration. The contrast agent is administered using a power injector before imaging.
GadobutrolOTHERGadobutrol at a dose less than or equal to 0.1 millimoles per kilogram (mmol/kg) will be given intravenously as a bolus using a power injector.
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Male or females over 18 years of age at the time of signing the informed consent. * Body weight \>=50 kilogram (kg) and Body Mass Index (BMI) within the range 18.0-40.0 kilogram/square meter (kg/m\^2) (inclusive). * Able to understand and comply with protocol requirements, ins...

Countries:United Kingdom
Unlock Eligibility Criteria